Gmo Benchmark-free Financials
| GBMBX Fund | USD 26.63 0.14 0.52% |
Gmo |
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Gmo Benchmark-free Fund Summary
Gmo Benchmark-free competes with Ultra-short Fixed, Calamos Global, Ab Select, Vanguard Equity, and Rbc Ultra-short. The fund is structured as a fund of funds and gains its investment exposures primarily by investing in Implementation Fund. GMO Benchmark-Free is traded on NASDAQ Exchange in the United States.| Instrument | USA Mutual Fund View All |
| Exchange | NMFQS Exchange |
| ISIN | US3620146072 |
| Business Address | GMO Trust |
| Mutual Fund Family | GMO |
| Mutual Fund Category | World Allocation |
| Benchmark | Dow Jones Industrial |
| Phone | 617 346 7646 |
| Currency | USD - US Dollar |
Gmo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gmo Benchmark-free's current stock value. Our valuation model uses many indicators to compare Gmo Benchmark-free value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gmo Benchmark-free competition to find correlations between indicators driving Gmo Benchmark-free's intrinsic value. More Info.Gmo Benchmark Free Allocation is one of the top funds in price to earning among similar funds. It also is one of the top funds in price to book among similar funds fabricating about 0.12 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Gmo Benchmark Free Allocation is roughly 8.63 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Benchmark-free's earnings, one of the primary drivers of an investment's value.Gmo Benchmark Free Systematic Risk
Gmo Benchmark-free's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gmo Benchmark-free volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Gmo Benchmark Free correlated with the market. If Beta is less than 0 Gmo Benchmark-free generally moves in the opposite direction as compared to the market. If Gmo Benchmark-free Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gmo Benchmark Free is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gmo Benchmark-free is generally in the same direction as the market. If Beta > 1 Gmo Benchmark-free moves generally in the same direction as, but more than the movement of the benchmark.
Gmo Benchmark-free November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Gmo Benchmark-free help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gmo Benchmark Free Allocation. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gmo Benchmark Free Allocation based on widely used predictive technical indicators. In general, we focus on analyzing Gmo Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gmo Benchmark-free's daily price indicators and compare them against related drivers.
| Information Ratio | (0.40) | |||
| Maximum Drawdown | 2.16 | |||
| Value At Risk | (0.92) | |||
| Potential Upside | 0.6664 |
Other Information on Investing in Gmo Mutual Fund
Gmo Benchmark-free financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Benchmark-free security.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |